Experimental T-cell therapy keeps four children with terminal brain cancer alive, three disease-free
An experimental immunotherapy has beaten aggressive brain tumours in a handful of children, and a personalised version is now being tested on more patients
Read the full articleYou might also wanna read
Could electric fields supercharge immune attack on the deadliest form of brain cancer?
LOS ANGELES — A new study led by Keck Medicine of USC researchers may have uncovered an effective combination therapy for glioblastoma, a br
New treatment may dramatically improve survival for those with deadly brain cancer
LOS ANGELES — High-grade astrocytoma, which includes glioblastoma, is a fast-growing, aggressive brain cancer that often returns after the t
New Generation CAR T-Cells For Cancer Therapy
New Generation CAR T-Cells For Cancer Therapy New Generation CAR T-Cells For Cancer Therapy migrate Tue, 02/06/2018 - 11:04 2018-02-06 With
Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trial
Phase 1/2a trial reports Temferon’s potential in GBM: 24 patients received stem cell transplants delivering INF-α2 to boost local antitumor
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Conditions : Diffuse Intrinsic Pontine Glioma; DIPG; Brain Tumor; CNS Tumor; Central Nervous System Tumor; Pediatric Cancer; Adult Cancer Pa
CAR T-cell therapy bolstered by stiffening up cancer cells first
CAR T-cell therapy has been hugely successful in treating certain types of tumours, and stiffening up cancer cells beforehand could make it
Comments
Sign in to join the conversation.
No comments yet. Be the first.